Dr. Joshua Woolley is the Director of the Translational Psychedelic Research (TrPR) Program at the University of California, San Francisco (UCSF), which brings together scientists and care providers across disciplines to understand how psilocybin, LSD, ketamine, MDMA, and related compounds impact the brain and other organ systems.